Paul Glowienka
Endocrinology, Diabetes & Metabolism · Beavercreek, OHNPI 1497753925
Payments from drug & device makers
Across 595 payments — averaging $17.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Novo Nordisk$1K
- Abbott$874
- Amgen$811
- Lilly USA, LLC$610
- Sanofi-aventis U.S. LLC$419
- plus $5K from 31 others
What the payments were for
- Travel & lodging$1,0009%
- Food & beverage$9,57390%
- Education$480%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 24 | $1,789 |
| Novo Nordisk | 93 | $1,434 |
| Abbott | 46 | $874 |
| Amgen(2 entities) | 50 | $811 |
| Lilly USA, LLC | 52 | $610 |
| Sanofi-aventis U.S. LLC | 27 | $419 |
| Amarin Pharma, Inc. | 34 | $405 |
| Boehringer Ingelheim | 25 | $373 |
| Antares Pharma, Inc. | 20 | $355 |
| Corcept Therapeutics | 14 | $294 |
| AstraZeneca | 15 | $288 |
| Insulet Corporation | 14 | $286 |
| Dexcom, Inc. | 22 | $279 |
| Zealand Pharma US, Inc. | 16 | $270 |
| Shire North American Group Inc | 8 | $242 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $208 |
| Lifescan, Inc. | 12 | $201 |
| Esperion Therapeutics, Inc. | 14 | $175 |
| Kowa Pharmaceuticals America, Inc. | 12 | $172 |
| Endo Pharmaceuticals Inc. | 10 | $136 |
| Merck | 9 | $122 |
| Johnson & Johnson | 8 | $108 |
| Clarus Therapeutics Inc. | 10 | $102 |
| Xeris Pharmaceuticals, Inc. | 7 | $95 |
| Tandem Diabetes Care, Inc. | 7 | $88 |
| AbbVie | 5 | $83 |
| Mannkind Corporation | 4 | $62 |
| Nestle Healthcare Nutrition Inc. | 3 | $57 |
| Radius Health, Inc. | 4 | $55 |
| Daiichi Sankyo Inc. | 3 | $54 |
| Regeneron Healthcare Solutions, Inc. | 3 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Evoke Pharma, Inc. | 2 | $28 |
| Valeritas, Inc. | 2 | $25 |
| Alfasigma USA, Inc. | 2 | $23 |
| Bayer | 1 | $12 |
| Acerus Pharmaceuticals Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 770G$970
- FreeStyle Libre 2$145
- FreeStyle Libre Pro$129
- Korlym$125
- SOLIQUA 100/33$123
- Wegovy$116
- INPEN SMART INSULIN DELIVERY SYSTEM$111
- XYOSTED$104
- Minimed 670G System$103
How this compares
$10,621 in reported general payments places this provider in the 75th percentile of 312 endocrinology, diabetes & metabolism providers in Ohio.
See all endocrinology, diabetes & metabolism providers in Ohio →
Other endocrinology, diabetes & metabolism in Beavercreek
- Toby BriskinBedford$9.8M
- Charles SmithCanton$5.3M
- Kevin PantaloneCleveland$4M
- Elena ChristofidesColumbus$3.5M
- Arvind KrishnaCanton$3.1M
- Bartolome BurgueraCleveland$3.1M
- Steven IngColumbus$1.9M
- Kathleen DunganColumbus$1.4M
- Kyaw SoeColumbus$1.3M
- John PaesWesterville$671K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.